The Advisory Research Inc. Maintains Stake in Eastman Chemical Company (EMN)
- by Xavier Trudeau
- in Financer
- — Fév 15, 2018
The institutional investor owned 25,267 shares of the basic materials company's stock after purchasing an additional 5,394 shares during the period. Hap Trading Llc who had been investing in Eastman Chem Co for a number of months, seems to be bullish on the $13.95 billion market cap company.
Eastman Chemical Company (EMN) stock price escalated 0.39% to finalize at $97.90 throughout previous buying and selling session. If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average - indicating a positive share price momentum.
Eastman Chemical (NYSE:EMN) last issued its quarterly earnings data on Thursday, February 1st. It has underperformed by 9.10% the S&P500. The total amount of shares outstanding is 144.30 million, giving the company a market capitalization of about 14.07 billion. The hedge fund run by Chao Ku held 8,300 shares of the major chemicals company at the end of 2017Q3, valued at $751,000, up from 2,600 at the end of the previous reported quarter. Argentiere Capital Ag who had been investing in Jpmorgan Chase & Co for a number of months, seems to be bullish on the $382.69 billion market cap company. The stock increased 0.66% or $0.76 during the last trading session, reaching $116.54. Most of the active traders and investors are keen to find ways to compare the value of stocks. (NYSE:JPM) has risen 33.74% since February 13, 2017 and is uptrending. It has underperformed by 41.19% the S&P500.
Investors sentiment increased to 1.18 in 2017 Q3. The company has managed to keep price to sales ratio of 1.75 against an industry average of 5.00. It increased, as 32 investors sold EMN shares while 175 reduced holdings. The basic materials company reported $1.62 EPS for the quarter, beating the Zacks' consensus estimate of $1.06 by $0.56. More interesting news about Eastman Chemical Company (NYSE:EMN) were released by: Seekingalpha.com and their article: "Eastman Chemical's (EMN) CEO Mark Costa on Q4 2017 Results - Earnings Call ..." published on February 02, 2018 as well as Streetinsider.com's news article titled: "Eastman Chemical (EMN) Approves Additional $2B Buyback, Provides Outlook" with publication date: February 06, 2018. Gateway Investment Advisers Ltd Co owns 34,978 shares or 0.02% of their United States portfolio. Finally, KeyCorp restated a "buy" rating and issued a $118.00 price target (up previously from $108.00) on shares of Eastman Chemical in a report on Monday, January 8th. Mitsubishi Ufj Tru &, a Japan-based fund reported 295,182 shares. Ascend reported 0.54% of its portfolio in Eastman Chemical Company (NYSE:EMN). Cambridge Advsr stated it has 16,796 shares or 0.02% of all its holdings. Davenport Lc has 20,013 shares for 0.02% of their portfolio. Oregon Public Employees Retirement Fund owns 39,638 shares. Legacy Private reported 18,103 shares. Janus Henderson Group PLC increased its stake in shares of Eastman Chemical by 38.6% in the second quarter.
Since August 22, 2017, it had 0 buys, and 4 sales for $1.65 million activity.
According to Eastman Chemical Company's latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 84.93%. $435,516 worth of Eastman Chemical Company (NYSE:EMN) shares were sold by WARMACK DAMON CARY. In the last 90 days, insiders have sold 63,417 shares of company stock worth $6,239,176. Therefore 53% are positive. Its revenue stood at -5.70% a year on average in the period of last five years. The firm has "Buy" rating given on Thursday, August 24 by KeyBanc Capital Markets. The rating was maintained by UBS with "Buy" on Friday, October 27. As per Tuesday, February 9, the company rating was downgraded by RBC Capital Markets. Macquarie Research maintained it with "Outperform" rating and $55 target in Tuesday, May 3 report. The stock of Eastman Chemical Company (NYSE:EMN) earned "Hold" rating by Standpoint Research on Tuesday, January 24. As per Friday, December 23, the company rating was maintained by Cowen & Co.
Eastman Chemical Company (Eastman) is an advanced materials and specialty additives company. The firm has "Underperform" rating by Credit Agricole given on Monday, May 2. As per Wednesday, January 3, the company rating was upgraded by Raymond James. It also reduced its holding in Community Finl Corp Md (NASDAQ:TCFC) by 42,917 shares in the quarter, leaving it with 209,719 shares, and cut its stake in Edison Intl (NYSE:EIX).
Investors sentiment decreased to 0.78 in 2017 Q3. Its up 0.05, from 0.92 in 2017Q2. Bessemer Grp Inc reported 0% of its portfolio in athenahealth, Inc. Confluence Wealth Limited Liability Com accumulated 4,892 shares. Evercore Wealth Mgmt invested in 0.07% or 34,585 shares. Avalon Global Asset Mngmt Limited Liability Corp stated it has 2.17% of its portfolio in athenahealth, Inc. Gulf Int Commercial Bank (Uk) Ltd reported 44,743 shares or 0.05% of all its holdings. Sivik Glob Ltd Llc reported 0.51% of its portfolio in athenahealth, Inc. Lazard Asset Mngmt Limited Co accumulated 0.06% or 316,739 shares.
Investors generally keep an extensive variety of technical indicators at their disposal for completing technical stock analysis. 83,407 are held by Cornercap Counsel Incorporated. Prudential Finance holds 712,235 shares. Synovus invested in 0.01% or 5,266 shares. Millennium Limited, New York-based fund reported 218,604 shares. Highvista Strategies Ltd holds 0.22% or 7,903 shares in its portfolio.
Among 28 analysts covering athenaHealth (NASDAQ:ATHN), 11 have Buy rating, 1 Sell and 16 Hold. Sysco Corporation had 56 analyst reports since August 6, 2015 according to SRatingsIntel.
Among 17 analysts covering Eastman Chemical Company (NYSE:EMN), 9 have Buy rating, 2 Sell and 6 Hold. The firm earned "Neutral" rating on Tuesday, October 10 by Nomura. The stock of Baxter International Inc. The firm has "Hold" rating by Boenning & Scattergood given on Wednesday, August 2. The firm has "Outperform" rating given on Tuesday, April 4 by Leerink Swann. The company was maintained on Friday, September 15 by Jefferies. The company now has an average rating of "Hold" and an average target price of $93.25.
The company also recently disclosed a quarterly dividend, which was paid on Monday, October 2nd.
COPYRIGHT VIOLATION NOTICE: "M&T Bank Corp Acquires 9,673 Shares of Eastman Chemical (EMN)" was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. SunTrust maintained athenahealth, Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.